David Ian Johnson, President and CEO at Alliqua BioMedical, Inc. (ALQA), bought 8,650 shares at $2.92 ($25K) on 2015-11-06, disclosed to the SEC on 2015-11-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |